Effect of Out-of-Pocket Cost on Medication Initiation, Adherence, and Persistence among Patients with Type 2 Diabetes: The Diabetes Study of Northern California (DISTANCE)

Health Services Research

Volumn 53, Issue 2, 2018, Pages 1227-1247

  Karter, Andrew J ^a,b   Parker, Melissa M ^a   Solomon, Matthew D ^a,c,d   Lyles, Courtney R ^a,e   Adams, Alyce S ^a   Moffet, Howard H ^a   Reed, Mary E ^a  

^a DIVISION OF RESEARCH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KAISER PERMANENTE   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

Adherence; medical expenditures; out of pocket costs; pharmacy benefits

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT;

ADULT; ARTICLE; COHORT ANALYSIS; COMORBIDITY; COST BENEFIT ANALYSIS; DEMOGRAPHY; DRUG COST; DRUG FORMULATION; DYSLIPIDEMIA; ELECTRONIC HEALTH RECORD; FEMALE; GLUCOSE INTAKE; HEALTH INSURANCE; HUMAN; HYPERTENSION; INTEGRATED HEALTH CARE SYSTEM; MAJOR CLINICAL STUDY; MALE; MEDICARE; MEDICATION COMPLIANCE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PATIENT EDUCATION; PHARMACEUTICAL CARE; REIMBURSEMENT; RISK FACTOR; SOCIAL STATUS; TREATMENT REFUSAL; TREATMENT WITHDRAWAL; AGED; CALIFORNIA; COST; ECONOMICS; FINANCIAL MANAGEMENT; HEALTH CARE COST; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; CALIFORNIA; COMORBIDITY; COST SHARING; DIABETES MELLITUS, TYPE 2; FEMALE; FINANCING, PERSONAL; HEALTH EXPENDITURES; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; SOCIOECONOMIC FACTORS;

EID: 85018394585     PISSN: 00179124     EISSN: 14756773     Source Type: Journal    
DOI: 10.1111/1475-6773.12700     Document Type: Article

References (57)

1. Bauer, A. M., D. Schillinger, M. M. Parker, W. Katon, N. Adler, A. S. Adams, H. H. Moffet, and A. J. Karter. 2013. “Health Literacy and Antidepressant Medication Adherence among Adults with Diabetes: The Diabetes Study of Northern California (DISTANCE).” Journal of General Internal Medicine 28 (9): 1181–7.
2. Berkowitz, S. A., H. K. Seligman, and N. K. Choudhry. 2014. “Treat or Eat: Food Insecurity, Cost-Related Medication Underuse, and Unmet Needs.” American Journal of Medicine 127 (4): 303–10 e303.
3. Bosworth, H. B., B. B. Granger, P. Mendys, R. Brindis, R. Burkholder, S. M. Czajkowski, J. G. Daniel, I. Ekman, M. Ho, M. Johnson, S. E. Kimmel, L. Z. Liu, J. Musaus, W. H. Shrank, E. Whalley, K. Weiss, and C. B. Granger. 2011. “Medication Adherence: A Call for Action.” American Heart Journal 162 (3): 412–24.
4. Briesacher, B. A., J. H. Gurwitz, and S. B. Soumerai. 2007. “Patients at-Risk for Cost-Related Medication Nonadherence: A Review of the Literature.” Journal of General Internal Medicine 22 (6): 864–71.
5. Bright, G. M., D. L. Kaiser, A. D. Rogol, and W. L. Clarke. 1983. “Naloxone Attenuates Recovery from Insulin-Induced Hypoglycemia in Normal Man.” Journal of Clinical Endocrinology and Metabolism 57 (1): 213–6.
6. Charlson, M., T. P. Szatrowski, J. Peterson, and J. Gold. 1994. “Validation of a Combined Comorbidity Index.” Journal of Clinical Epidemiology 47 (11): 1245–51.
7. Cheung, Y. B. 2007. “A Modified Least-Squares Regression Approach to the Estimation of Risk Difference.” American Journal of Epidemiology 166 (11): 1337–44.
8. Clarke, W. L., W. R. Carter, M. Moll, D. J. Cox, L. A. Gonder-Frederick, and P. E. Cryer. 1988. “Metabolic and Cutaneous Events Associated with Hypoglycemia Detected by Sleep Sentry.” Diabetes Care 11 (8): 630–5.
9. Clarke, W. L., J. V. Santiago, L. Thomas, E. Ben-Galim, M. W. Haymond, and P. E. Cryer. 1979. “Adrenergic Mechanisms in Recovery from Hypoglycemia in Man: Adrenergic Blockade.” American Journal of Physiology 236 (2): E147–52.
10. Clarke, W. L., and A. L. Snyder. 1990. “Hypoglycemia. Can the School Respond?” Diabetes Care 13 (10): 1097–8.
11. Claxton, G., M. Rae, N. Panchal, H. Whitmore, A. Damico, and K. Kenward. 2014. “Health Benefits in 2014: Stability in Premiums and Coverage for Employer-Sponsored Plans.” Health Affairs 33 (10): 1851–60.
12. Collier, A., D. J. Steedman, A. W. Patrick, G. R. Nimmo, D. M. Matthews, C. C. MacIntyre, K. Little, and B. F. Clarke. 1987. “Comparison of Intravenous Glucagon and Dextrose in Treatment of Severe Hypoglycemia in an Accident and Emergency Department.” Diabetes Care 10 (6): 712–5.
13. Duru, O. K., J. A. Schmittdiel, W. T. Dyer, M. M. Parker, C. S. Uratsu, J. Chan, and A. J. Karter. 2010. “Mail-Order Pharmacy Use and Adherence to Diabetes-Related Medications.” American Journal of Managed Care 16 (1): 33–40.
14. Eaddy, M. T., C. L. Cook, K. O'Day, S. P. Burch, and C. R. Cantrell. 2012. “How Patient Cost-Sharing Trends Affect Adherence and Outcomes: A Literature Review.” Pharmacy and Therapeutics 37 (1): 45–55.
15. Ekedahl, A., and N. Mansson. 2004. “Unclaimed Prescriptions after Automated Prescription Transmittals to Pharmacies.” Pharmacy World & Science 26 (1): 26–31.
16. Engler, D., T. Pham, M. J. Fullerton, G. Ooi, J. W. Funder, and I. J. Clarke. 1989. “Studies of the Secretion of Corticotropin-Releasing Factor and Arginine Vasopressin into the Hypophysial-Portal Circulation of the Conscious Sheep. I. Effect of an Audiovisual Stimulus and Insulin-Induced Hypoglycemia.” Neuroendocrinology 49 (4): 367–81.
17. Fischer, M. A., M. R. Stedman, J. Lii, C. Vogeli, W. H. Shrank, M. A. Brookhart, and J. S. Weissman. 2010. “Primary Medication Non-Adherence: Analysis of 195,930 Electronic Prescriptions.” Journal of General Internal Medicine 25 (4): 284–90.
18. Gatwood, J., T. B. Gibson, M. E. Chernew, A. M. Farr, E. Vogtmann, and A. M. Fendrick. 2014. “Price Elasticity and Medication use: Cost Sharing Across Multiple Clinical Conditions.” Journal of Managed Care Pharmacy 20 (11): 1102–7.
19. Gibson, T. B., R. J. Ozminkowski, and R. Z. Goetzel. 2005. “The Effects of Prescription Drug Cost Sharing: A Review of the Evidence.” American Journal of Managed Care 11 (11): 730–40.
20. Gibson, T. B., S. Wang, E. Kelly, C. Brown, C. Turner, F. Frech-Tamas, J. Doyle, and E. Mauceri. 2011. “A Value-Based Insurance Design Program at a Large Company Boosted Medication Adherence for Employees with Chronic Illnesses.” Health Affairs 30 (1): 109–17.
21. Goldman, D. P., G. F. Joyce, and Y. Zheng. 2007. “Prescription Drug Cost Sharing: Associations with Medication and Medical Utilization and Spending and Health.” Journal of the American Medical Association 298 (1): 61–9.
22. Greenland, S., J. Pearl, and J. M. Robins. 1999. “Causal Diagrams for Epidemiologic Research.” Epidemiology 10 (1): 37–48.
23. Hernan, M. A., S. Hernandez-Diaz, M. M. Werler, and A. A. Mitchell. 2002. “Causal Knowledge as a Prerequisite for Confounding Evaluation: An Application to Birth Defects Epidemiology.” American Journal of Epidemiology 155 (2): 176–84.
24. Institute for Health Care Research and Policy. 2002. “Prescription Drugs.” Data Profile Number 5 [accessed on April 6, 2017]. Available at https://hpi.georgetown.edu/agingsociety/pubhtml/rxdrugs/rxdrugs.html
25. Kahneman, D., and A. Tverksy. 1992. “Advances in Prospect Theory: Cumulative Representation of Uncertainty.” Journal of Risk and Uncertainty 5 (4): 297–323.
26. Karter, A. J., M. M. Parker, A. S. Adams, H. H. Moffet, J. A. Schmittdiel, A. T. Ahmed, and J. V. Selby. 2009. “New Prescription Medication Gaps: A Comprehensive Measure of Adherence to New Prescriptions.” Health Services Research 44 (5 Pt 1): 1640–61.
27. Karter, A. J., H. H. Moffet, A. T. Ahmed, J. A. Schmittdiel, and J. V. Selby. 2010. “Primary Non-Adherence to Prescribed Medications.” Journal of General Internal Medicine 25 (8): 763; author reply 765.
28. Katon, W., C. R. Lyles, M. M. Parker, A. J. Karter, E. S. Huang, and R. A. Whitmer. 2012. “Association of Depression with Increased Risk of Dementia in Patients with Type 2 Diabetes: The Diabetes and Aging Study.” Archives of General Psychiatry 69 (4): 410–7.
29. Katon, W., J. Russo, E. H. Lin, S. R. Heckbert, A. J. Karter, L. H. Williams, P. Ciechanowski, E. Ludman, and M. Von Korff. 2009. “Diabetes and Poor Disease Control: Is Comorbid Depression Associated with Poor Medication Adherence or Lack of Treatment Intensification?” Psychosomatic Medicine 71 (9): 965–72.
30. Keeler, E. B., and J. E. Rolph. 1988. “The Demand for Episodes of Treatment in the Health Insurance Experiment.” Journal of Health Economics 7: 337–67.
31. Kirkman, M. S., M. T. Rowan-Martin, R. Levin, V. A. Fonseca, J. A. Schmittdiel, W. H. Herman, and R. E. Aubert. 2015. “Determinants of Adherence to Diabetes Medications: Findings from a Large Pharmacy Claims Database.” Diabetes Care 38 (4): 604–9.
32. Li, R., L. E. Barker, S. Shrestha, P. Zhang, O. K. Duru, T. Pearson-Clarke, and E. W. Gregg. 2014. “Changes over Time in High Out-of-Pocket Health-Care Burden in U.S. Adults With Diabetes, 2001–2011.” Diabetes Care 37 (6): 1629–35.
33. Mann, B. S., L. Barnieh, K. Tang, D. J. Campbell, F. Clement, B. Hemmelgarn, M. Tonelli, D. Lorenzetti, and B. J. Manns. 2014. “Association between Drug Insurance Cost Sharing Strategies and Outcomes in Patients with Chronic Diseases: A Systematic Review.” PLoS ONE 9 (3): e89168.
34. McCoy, R. G., K. J. Lipska, X. Yao, J. S. Ross, V. M. Montori, and N. D. Shah. 2016. “Intensive Treatment and Severe Hypoglycemia among Adults with Type 2 Diabetes.” JAMA Internal Medicine 176 (7): 969–78.
35. Messer, L. C., B. A. Laraia, J. S. Kaufman, J. Eyster, C. Holzman, J. Culhane, I. Elo, J. G. Burke, and P. O'Campo. 2006. “The Development of a Standardized Neighborhood Deprivation Index.” Journal of Urban Health 83 (6): 1041–62.
36. Moffet, H. H., N. Adler, D. Schillinger, A. T. Ahmed, B. Laraia, J. V. Selby, R. Neugebauer, J. Y. Liu, M. M. Parker, M. Warton, and A. J. Karter. 2009. “Cohort Profile: The Diabetes Study of Northern California (DISTANCE)–Objectives and Design of a Survey Follow-up Study of Social Health Disparities in a Managed Care Population.” International Journal of Epidemiology 38 (1): 38–47.
37. Mojtabai, R., and M. Olfson. 2003. “Medication Costs, Adherence, and Health Outcomes among Medicare Beneficiaries.” Health Affairs (Millwood) 22 (4): 220–9.
38. Ouellette, J. A., and W. Wood. 1998. “Habit and Intention in Everyday Life: The Multiple Processes by Which Past Behavior Predicts Future Behavior.” Psychological Bulletin 124 (1): 20.
39. Park, T., and J. Jung. 2017. “The Effect of Medicare Part D on Prescription Drug Spending and Health Care Use: 6 Years of Follow-up, 2007–2012.” Journal of Managed Care & Specialty Pharmacy 23 (1): 5–12.
40. Parker, M. M., H. H. Moffet, A. Adams, and A. J. Karter. 2015. “An Algorithm to Identify Medication Nonpersistence Using Electronic Pharmacy Databases.” Journal of the American Medical Informatics Association: JAMIA 22(5): 957–61.
41. Piette, J. D., M. Heisler, and T. H. Wagner. 2004. “Cost-Related Medication Underuse: Do Patients with Chronic Illnesses Tell Their Doctors?” Archives of Internal Medicine 164 (16): 1749–55.
42. Piette, J. D., and T. H. Wagner. 2006. “Medication Characteristics beyond Cost Alone Influence Decisions to Underuse Pharmacotherapy in Response to Financial Pressures.” Journal of Clinical Epidemiology 59 (7): 739–46.
43. Piette, J. D., R. Horne, and G. Caleb Alexander. 2006. “A Conceptually Based Approach to Understanding Chronically ill Patients’ Responses to Medication Cost Pressures.” Social Science and Medicine 62 (4): 846–57.
44. Piette, J. D., A. Beard, A. M. Rosland, and C. A. McHorney. 2011. “Beliefs That Influence Cost-Related Medication non-Adherence among the “Haves” and “Have Nots” with Chronic Diseases.” Patient Prefer Adherence 5: 389–96.
45. Pilote, L., C. Beck, H. Richard, and M. J. Eisenberg. 2002. “The Effects of Cost-Sharing on Essential Drug Prescriptions, Utilization of Medical Care and Outcomes after Acute Myocardial Infarction in Elderly Patients.” Canadian Medical Association Journal 167: 246–52.
46. Raebel, M. A., J. Schmittdiel, A. J. Karter, J. L. Konieczny, and J. F. Steiner. 2013. “Standardizing Terminology and Definitions of Medication Adherence and Persistence in Research Employing Electronic Databases.” Medical Care 51 (8 Suppl 3): S11–21.
47. Ratanawongsa, N., A. J. Karter, M. M. Parker, C. R. Lyles, M. Heisler, H. H. Moffet, N. Adler, E. M. Warton, and D. Schillinger. 2013. “Communication and Medication Refill Adherence: The Diabetes Study of Northern California.” JAMA Internal Medicine 173 (3): 210–8.
48. Riggs, K. R., and P. A. Ubel. 2014. “Overcoming Barriers to Discussing Out-of-Pocket Costs with Patients.” JAMA Internal Medicine 174 (6): 849–50.
49. Rodriguez-Gutierrez, R., K. J. Lipska, and R. G. McCoy. 2016. “Intensive Glycemic Control in Type 2 Diabetes Mellitus—A Balancing Act of Latent Benefit and Avoidable Harm: A Teachable Moment.” JAMA Internal Medicine 176 (3): 300–1.
50. Rosenbaum, L. 2015. “Beyond Belief—How People Feel about Taking Medications for Heart Disease.” New England Journal of Medicine 372 (2): 183–7.
51. Schmittdiel, J., M. Raebel, W. Dyer, J. Steiner, G. Goodrich, A. Karter, and G. Nichols. 2014. “Medicare Star Excludes Diabetes Patients with Poor CVD Risk Factor Control.” American Journal of Managed Care 20 (12): e573–81.
52. Seabury, S. A., D. N. Lakdawalla, J. S. Dougherty, J. Sullivan, and D. P. Goldman. 2015. “Medication Adherence and Measures of Health Plan Quality.” American Journal of Managed Care 21 (6): e379–89.
53. Simoens, S., and P. R. Sinnaeve. 2014. “Patient co-Payment and Adherence to Statins: A Review and Case Studies.” Cardiovascular Drugs and Therapy 28 (1): 99–109.
54. Solomon, M. D., D. P. Goldman, G. F. Joyce, and J. J., Escarce. 2009. “Cost Sharing and the Initiation of Drug Therapy for the Chronically Ill.” Archives of Internal Medicine 169 (8): 740–8; discussion 748–749.
55. Steiner, J. F., T. D. Koepsell, S. D. Fihn, and T. S. Inui. 1988. “A General Method of Compliance Assessment Using Centralized Pharmacy Records. Description and Validation.” Medical Care 26: 814–23.
56. Tang, K. L., L. Barnieh, B. Mann, F. Clement, D. J. Campbell, B. R. Hemmelgarn, M. Tonelli, D. Lorenzetti, and B. J. Manns. 2014. “A Systematic Review of Value-Based Insurance Design in Chronic Diseases.” American Journal of Managed Care 20 (6): e229–41.
57. Zou, G. 2004. “A Modified Poisson Regression Approach to Prospective Studies with Binary Data.” American Journal of Epidemiology 159 (7): 702–6.